School of Medicine
Showing 1-47 of 47 Results
-
Yiyun Chen
Postdoctoral Scholar, Stanford Cancer Center
BioYiyun Chen, Ph.D. is a Postdoctoral Fellow at Professor Crystal Mackall’s group at Stanford Cancer Institute.
Dr. Chen studied biochemistry and structural biology in her undergraduate and master trainings at The Hong Kong University of Science and Technology, where she eventually obtained her Ph.D. degree in computational biology under the supervision of Professor Jiguang Wang. During her Ph.D. training, she has developed her skill sets in analyzing and integrating various types of patient-derived sequencing data, published three first-author and four co-author papers, and received two awards for top postgraduate students. Through interdisciplinary collaborations with cancer biologist and clinicians in US and Asia, her work has uncovered tumor-specific immune cell subtypes and novel noncoding RNAs and generated new insights into precision medicine in glioma, lymphoma and gastric cancer.
Applying her expertise in computational cancer biology and immunology, her current research is focused on identifying molecular mechanisms that contribute to the clinical outcomes of patients undergoing CAR-T immunotherapy. At Mackall Lab, she will contribute to tailoring computational pipelines for profiling the spatiotemporal dynamics of the tumor and immune microenvironment and translate new discoveries into cancer therapeutics. -
Jordan C. Cheng, DMD, PhD
Postdoctoral Scholar, Stanford Cancer Center
Current Research and Scholarly InterestsMy reserach direction involves evlaution single-stranded library prepartion methods for cell-free DNA analysis and the biology of plasma ultrashort cell-free DNA.
-
Cathy Garcia
Postdoctoral Scholar, Stanford Cancer Center
Current Research and Scholarly InterestsIslet biology, diabetes, obesity, pancreatic cancer
-
Maximilian Koch
Postdoctoral Scholar, Stanford Cancer Center
Current Research and Scholarly InterestsMy current research is in the development of new cellular immunotherapies for pediatric cancers.
This includes the identification of suitable MHC-restricted and native antigens expressed by the malignant cells but ideally not by healthy tissues. On the receptor side, both CARs and TCRs will be characterized for specificity, affinity, and functionality. Ultimately, non-viral introduction approaches will be exploited and refined to achieve cheap, precise and consistent cell products. -
Lise Mangiante
Postdoctoral Scholar, Stanford Cancer Center
Current Research and Scholarly InterestsMy research focused on understanding the evolution and ecology of cancer, and determinants of disease progression through analysis and modeling of high-dimensional, clinically annotated datasets.
-
Sean Yamada-Hunter
Postdoctoral Scholar, Stanford Cancer Center
BioI am a postdoc in Crystal Mackall's lab at Stanford and a Parker Institute for Cancer Immunotherapy Parker Scholar. I specialize in applying synthetic biology and protein engineering approaches to cellular immunotherapy, with a particular interest in facilitating potent combination immunotherapies, most recently through dual treatment of CAR T therapy and CD47 blockade.
-
An Ni Zhang
Postdoctoral Scholar, Stanford Cancer Center
BioAnni obtained her Ph.D. in Dr. James Johnson and Dr. Janel Kopp's labs at the University of British Columbia. Her Ph.D. work showed that hyperinsulinemia contributes to pancreatic cancer development. Her work also showed that insulin directly acted via the insulin receptors in pancreatic acinar cells to increase digestive enzyme production, thereby generating an inflammatory condition that accelerates neoplastic transformation. She is now working at Diehn lab to investigate the mechanisms of KEAP1 mutation-induced immunotherapy resistance in lung cancer.
